DKK1 and type 2 diabetes mellitus: Since sclerostin and DKK1 levels are significantly elevated in diabetes [12,13,51,52,53,54,55,56] and Wnt pathways also participate in glucose metabolism and T2DM development [57], recent studies have begun to focus on whether these antibodies also exert an effect on glucose homeostasis.